11 Einträge gefunden

1. Post-Transplantation Multicolored Flow Cytometry-Minimal Residual Disease Status on Day 100 Predicts Outcomes for Patients With Refractory Acute Myeloid Leukemia

   1. Klyuchnikov, Evgeny
   2. Badbaran, Anita
   3. Massoud, Radwan
   4. Fritsche-Friedland, Ulrike
   5. Janson, Dietlinde
   6. Ayuk, Francis
   7. Christopeit, Maximilian

   2022 - Forschungsinformationssystem des UKE
2. Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission

   1. Klyuchnikov, Evgeny
   2. Badbaran, Anita
   3. Massoud, Radwan
   4. Fritzsche-Friedland, Ulrike
   5. Freiberger, Petra
   6. Ayuk, Francis
   7. Wolschke, Christine

   2022 - Forschungsinformationssystem des UKE
3. Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia

   1. Klyuchnikov, Evgeny
   2. Badbaran, Anita
   3. Massoud, Radwan
   4. Fritsche-Friedland, Ulrike
   5. Janson, Dietlinde
   6. Ayuk, Francis
   7. Wolschke, Christine

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Role of pre-transplant MRD level detected by flow cytometry in recipients of allogeneic stem cell transplantation with AML

   1. Klyuchnikov, Evgeny
   2. Christopeit, Maximilian
   3. Badbaran, Anita
   4. Bacher, Ulrike
   5. Fritsche-Friedland, Ulrike
   6. von Pein, Ute-Marie
   7. Wolschke, Christine

   2021 - Forschungsinformationssystem des UKE
5. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

   1. Fu, Yuewen
   2. Schroeder, Thomas
   3. Zabelina, Tatiana
   4. Badbaran, Anita
   5. Bacher, Ulrike
   6. Kobbe, Guido
   7. Ayuketang, Francis Ayuk

   2014 - Forschungsinformationssystem des UKE
6. Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.

   1. Alchalby, Haefaa
   2. Badbaran, Anita
   3. Bock, O
   4. Fehse, Boris
   5. Bacher, Ulrike
   6. Zander, Axel R.
   7. Kröger, Nicolaus

   2010 - Forschungsinformationssystem des UKE
7. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

   1. Bacher, Ulrike
   2. Badbaran, Anita
   3. Fehse, Boris
   4. Zabelina, Tatjana
   5. Zander, Axel R.
   6. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
8. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

   1. Kröger, Nicolaus
   2. Alchalby, Haefaa
   3. Klyuchnikov, Evgeny
   4. Badbaran, Anita
   5. Hildebrandt, York
   6. Ayuketang Ayuk, Francis
   7. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
9. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

   1. Lioznov, Michael
   2. El-Cheikh, J
   3. Hoffmann, Friedericke
   4. Hildebrandt, York
   5. Ayuketang Ayuk, Francis
   6. Wolschke, Christine
   7. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE
10. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

    1. Kröger, Nicolaus
    2. Badbaran, Anita
    3. Lioznov, Michael
    4. Schwartz, Sabine
    5. Zeschke, Silke
    6. Hildebrandt, York
    7. Ayuketang Ayuk, Francis

    2009 - Forschungsinformationssystem des UKE
11. Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.

    1. Bacher, Ulrike
    2. Asenova, Svetlana
    3. Badbaran, Anita
    4. Zander, Axel R.
    5. Alchalby, Haefaa
    6. Fehse, Boris
    7. Kröger, Nicolaus

    2009 - Forschungsinformationssystem des UKE